RNAZ
TransCode Therapeutics (RNAZ)
$78
About TransCode Therapeutics (RNAZ)
TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. The company was founded by Robert Michael Dudley, Zdravka Medarova, and Anna Moore in January 2016 and is headquartered in Newton, MA.
Details
Daily high
$0.89
Daily low
$0.68
Price at open
$0.75
52 Week High
$66.33
52 Week Low
$0.64
Market cap
543,100
Dividend yield
0.00%
Volume
3.6M
Avg. volume
2.5M
P/E ratio
.00
TransCode Therapeutics News
Details
Daily high
$0.89
Daily low
$0.68
Price at open
$0.75
52 Week High
$66.33
52 Week Low
$0.64
Market cap
543,100
Dividend yield
0.00%
Volume
3.6M
Avg. volume
2.5M
P/E ratio
.00